These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1441044)

  • 21. The efficacy of norfloxacin in the treatment of urinary tract infections in Tikure Anbessa Hospital, Addis Ababa, Ethiopia.
    Mengesha B
    East Afr Med J; 1991 Nov; 68(11):844-52. PubMed ID: 1800077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative efficacy of sparfloxacin versus ciprofloxacin in the treatment of complicated urinary tract infection.
    Naber KG; di Silverio F; Geddes A; Guibert J
    J Antimicrob Chemother; 1996 May; 37 Suppl A():135-44. PubMed ID: 8737133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Norfloxacin in the treatment of complicated and uncomplicated urinary tract infections. A comparative multicenter trial.
    Goldstein EJ; Alpert ML; Najem A; Eng RH; Ginsburg BP; Kahn RM; Cherubin CE
    Am J Med; 1987 Jun; 82(6B):65-9. PubMed ID: 3300313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ciprofloxacin 250 mg twice daily versus ofloxacin 200 mg twice daily in the treatment of complicated urinary tract infections in women.
    Raz R; Naber KG; Raizenberg C; Rohana Y; Unamba-Oparah I; Korfman G; Yaniv I
    Eur J Clin Microbiol Infect Dis; 2000 May; 19(5):327-31. PubMed ID: 10898131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for urinary tract infections due to ciprofloxacin-resistant Escherichia coli in a tertiary care urology department in Switzerland.
    Nicoletti J; Kuster SP; Sulser T; Zbinden R; Ruef C; Ledergerber B; Weber R
    Swiss Med Wkly; 2010; 140():w13059. PubMed ID: 20648400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double-blind, randomized comparison of 24 weeks of norfloxacin and 12 weeks of norfloxacin followed by 12 weeks of placebo in the therapy of complicated urinary tract infection.
    Sheehan GJ; Harding GK; Haase DA; Thomson MJ; Urias B; Kennedy JK; Hoban DJ; Ronald AR
    Antimicrob Agents Chemother; 1988 Aug; 32(8):1292-3. PubMed ID: 3056259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fleroxacin versus norfloxacin in the treatment of urinary tract infections: a multicenter, double-blind, prospective, randomized, comparative study.
    Pummer K
    Am J Med; 1993 Mar; 94(3A):108S-113S. PubMed ID: 8452165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single dose quinolone treatment in acute uncomplicated urinary tract infection in women.
    Pfau A; Sacks TG
    J Urol; 1993 Mar; 149(3):532-4. PubMed ID: 8437256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review of norfloxacin in complicated and recurrent urinary tract infections.
    Schaeffer AJ
    Eur Urol; 1990; 17 Suppl 1():19-23. PubMed ID: 2191865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Norfloxacin versus nalidixic acid in the treatment of urinary tract infections.
    Karachalios GN; Georgiopoulos AN
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):317-9. PubMed ID: 3623736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral fosfomycin versus ciprofloxacin in women with E.coli febrile urinary tract infection, a double-blind placebo-controlled randomized controlled non-inferiority trial (FORECAST).
    Ten Doesschate T; van Mens SP; van Nieuwkoop C; Geerlings SE; Hoepelman AIM; Bonten MJM
    BMC Infect Dis; 2018 Dec; 18(1):626. PubMed ID: 30518334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppressive therapy with norfloxacin in patients with recurrent and/or complicated urinary tract infection.
    Falck L; Bucht H; Stegmayr B; Svärd R
    Scand J Urol Nephrol Suppl; 1988; 110():307-11. PubMed ID: 3055255
    [No Abstract]   [Full Text] [Related]  

  • 33. Use of ciprofloxacin versus use of aminoglycosides for therapy of complicated urinary tract infection: prospective, randomized clinical and pharmacokinetic study.
    Fang GD; Brennen C; Wagener M; Swanson D; Hilf M; Zadecky L; DeVine J; Yu VL
    Antimicrob Agents Chemother; 1991 Sep; 35(9):1849-55. PubMed ID: 1952856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the safety and efficacy of intravenous ciprofloxacin and intravenous ceftazidime in the treatment of selected infections.
    Gallis HA; Brennan RO; Goodwin SD; Swinney V; Rumbaugh MM; Drew RH
    Am J Med; 1989 Nov; 87(5A):176S-180S. PubMed ID: 2686418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Once-daily fleroxacin versus twice-daily ciprofloxacin in the treatment of complicated urinary tract infections.
    Frankenschmidt A; Naber KG; Bischoff W; Kullmann K
    J Urol; 1997 Oct; 158(4):1494-9. PubMed ID: 9302150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of lomefloxacin as compared to norfloxacin in the treatment of uncomplicated urinary tract infections in adults.
    Iravani A
    Am J Med; 1992 Apr; 92(4A):75S-81S. PubMed ID: 1316075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of acute uncomplicated urinary tract infections with 3 days of lomefloxacin compared with treatment with 3 days of norfloxacin.
    Nicolle LE; DuBois J; Martel AY; Harding GK; Shafran SD; Conly JM
    Antimicrob Agents Chemother; 1993 Mar; 37(3):574-9. PubMed ID: 8384818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of bacterial infection in neutropenic patients with hematologic malignancies. A randomized, multicenter trial comparing norfloxacin with ciprofloxacin. The GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
    Ann Intern Med; 1991 Jul; 115(1):7-12. PubMed ID: 2048868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral ciprofloxacin in resistant urinary tract infections.
    Ryan JL; Berenson CS; Greco TP; Mangi RJ; Sims M; Thornton GF; Andriole VT
    Am J Med; 1987 Apr; 82(4A):303-6. PubMed ID: 3555052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fleroxacin versus norfloxacin for oral treatment of serious urinary tract infections.
    Childs SJ
    Am J Med; 1993 Mar; 94(3A):105S-107S. PubMed ID: 8452164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.